These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16856988)
1. Use of an immune function assay to monitor immunosuppression. Grimm P Pediatr Transplant; 2006 Aug; 10(5):533-5. PubMed ID: 16856988 [No Abstract] [Full Text] [Related]
2. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival. Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959 [TBL] [Abstract][Full Text] [Related]
3. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Gautam A; Morrissey PE; Brem AS; Fischer SA; Gohh RY; Yango AF; Monaco AP Pediatr Transplant; 2006 Aug; 10(5):613-6. PubMed ID: 16856999 [TBL] [Abstract][Full Text] [Related]
4. Transplantation: new protocols and new worries. Grinyo JM Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802 [No Abstract] [Full Text] [Related]
5. Clinical relevance of immune monitoring in solid organ transplantation. Daniel V; Opelz G Int Rev Immunol; 2009; 28(3-4):155-84. PubMed ID: 19811320 [TBL] [Abstract][Full Text] [Related]
6. [Humoral immunity and kidney transplantation. Possibilities and desensitizing treatment]. Rowshani AT; Lardy NM; Surachno JS; ten Berge RJ Ned Tijdschr Geneeskd; 2009 Mar; 153(13):612-6. PubMed ID: 19408538 [No Abstract] [Full Text] [Related]
8. Post-transplant monitoring of renal allografts: are we there yet? Nickerson P Curr Opin Immunol; 2009 Oct; 21(5):563-8. PubMed ID: 19713093 [TBL] [Abstract][Full Text] [Related]
9. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Zeevi A; Britz JA; Bentlejewski CA; Guaspari D; Tong W; Bond G; Murase N; Harris C; Zak M; Martin D; Post DR; Kowalski RJ; Elmagd KA Transpl Immunol; 2005 Oct; 15(1):17-24. PubMed ID: 16223669 [TBL] [Abstract][Full Text] [Related]
11. Cell mediated immunity (CMI) and post transplant viral infections--role of a functional immune assay to titrate immunosuppression. Gautam A; Fischer SA; Yango AF; Gohh RY; Morrissey PE; Monaco AP Int Immunopharmacol; 2006 Dec; 6(13-14):2023-6. PubMed ID: 17161357 [TBL] [Abstract][Full Text] [Related]
12. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation? Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740 [TBL] [Abstract][Full Text] [Related]
14. Can we use biomarkers and functional assays to implement personalized therapies in transplantation? Sawitzki B; Pascher A; Babel N; Reinke P; Volk HD Transplantation; 2009 Jun; 87(11):1595-601. PubMed ID: 19502949 [TBL] [Abstract][Full Text] [Related]
15. Evolution of immunosuppression in kidney transplantation: the Ohio State University experience. Rajab A; Pelletier RP; Henry ML; Elkhammas EA; Bumgardner GL; Davies EA; Orosz CG; Ferguson RM Clin Transpl; 2005; ():111-7. PubMed ID: 17424729 [TBL] [Abstract][Full Text] [Related]
16. New directions for induction immunosuppression strategy in solid organ transplantation. Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743 [TBL] [Abstract][Full Text] [Related]
17. Can immune monitoring help to minimize immunosuppression in kidney transplantation? Ashton-Chess J; Giral M; Soulillou JP; Brouard S Transpl Int; 2009 Jan; 22(1):110-9. PubMed ID: 18764832 [TBL] [Abstract][Full Text] [Related]